LGALS4 and bladder transitional cell carcinoma: It is reported that LGALS4, a β-galactoside binding protein, is correlated with prognosis in urothelial carcinoma of bladder and is also a tumor marker in serum immunoassay determination of colorectal carcinoma24,25.